Search results for "ORPHAN DRUG|Designated|Treatment of Stage IIB through Stage IV malignant melanoma." in comments (approximate match)
Showing 1 - 2 of 2 results
Thymalfasin, a synthetic version of thymosin-α-1, a polypeptide (protein fragment) was being developed by SciClone Pharmaceuticals for the treatment of liver disease. SciClone developed and launched Thymalfasin, under the trade name Zadaxin, for the ...
